SiNOPSEE Therapeutics Pvt Ltd

SiNOPSEE Therapeutics Pvt Ltd is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about SiNOPSEE Therapeutics Pvt Ltd. SiNOPSEE THERAPEUTICS Pvt Ltd is a bio-pharmaceutical company focused on the discovery, design and development of small molecular weight compounds for the treatment of chronic diseases. Originating from the scientifically accredited Agency for Science, Technology & Research (A*STAR), the R&D HQ and the main holding is based out of Singapore. SiNOPSEE’s small molecule inhibitors were identified using a versatile high through-put screening technology and were optimized for potency & selectivity, employing in-silico molecular modelling techniques. Our lead molecules exhibit sig. potency, selectivity and show excellent promise in in-vitro (cell lines), ex-vivo (organoid) & in-vivo (rodent) models [Confidential Information Memorandum (CIM) will be available, on request, for deeper due diligence]. SiNOPSEE will develop its lead molecule to early stage clinical trials. Briefly our business strategy is to subsequently out-licence or co-develop the compound(s) to(/with) major pharmaceutical players for advanced clinical trials and commercialization.